Li, J., Qin, S., Xu, R., Yau, T. C. C., Ma, B., Pan, H., Xu, J., Bai, Y., Chi, Y., Wang, L., Yeh, K., Bi, F., Cheng, Y., Le, A. T., Lin, J., Liu, T., Ma, D., Kappeler, C., Kalmus, J., Kim, T. W., & , (n.d.). regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet oncology, 16(6), 619–629. http://access.bl.uk/ark:/81055/vdc_100051216994.0x000022